IP Library › Assignment 044661/0043
Patent Assignment
Reel/Frame 044661/0043

Assignment of Assignor's Interest

Recorded: 2018-01-18 Pages: 11
Assignors
FADINI, LUCA
Executed: 2012-12-07
MANINI, PETER
Executed: 2012-12-07
PIETRA, CLAUDIO
Executed: 2012-12-07
GIULIANO, CLAUDIO
Executed: 2012-12-07
LOVATI, EMANUELA
Executed: 2012-12-07
CANNELLA, ROBERTA
Executed: 2012-12-07
VENTURINI, ALESSIO
Executed: 2012-12-07
STELLA, VALENTINO J
Executed: 2013-01-22
Assignee
HELSINN HEALTHCARE SA
VIA PIAN SCAIROLO 9, LUGANO/PAZZALLO, CH-6912, SWITZERLAND
Covered Property (1)
SOLUTION COMPRISING THE CHLORIDE HYDROCHLORIDE SALT OF 4-(5-(2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-N,2-DIMETHYLPROPANAMIDO)-4-(o-TOLYL)PYRIDIN-2-YL)-1-METHYL-1-((PHOSPHONOOXY)METHYL)PIPERAZIN-1-IUM (FOSNETUPITANT) AND PALONOSETRON HYDROCHLORIDE IN COMBINATION WITH DEXAMETHASONE AS A NEUROKININ RECEPTOR MODULATOR
Application: 15/874,325 →
Publication: US 2018/0194788
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Dec 30, 2022
From: HELSINN HEALTHCARE SA; HELSINN THERAPEUTICS (U.S.), INC.; HELSINN BIREX PHARMACEUTICALS LIMITED
To: HAMILTON SA LLC
Reel/Frame 062254/0888 →
Release of Security Interest Sep 20, 2023
From: HAMILTON SA LLC
To: HELSINN HEALTHCARE SA; HELSINN THERAPEUTICS (U.S.), INC.; HELSINN BIREX PHARMACEUTICALS LIMITED
Reel/Frame 064961/0567 →